Response to "Letter Regarding: Anti-RANKL Antibody for Active Charcot Foot Neuro-osteoarthropathy in Patients With Diabetes and Chronic Kidney Disease"

Foot Ankle Int. 2025 Jan;46(1):130-131. doi: 10.1177/10711007241302754.
No abstract available

Publication types

  • Letter